Avidity

0 followers


Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Sarah Boyce
President & CEO

Sarah Boyce

Collapse
Michael MacLean
Chief Financial & Business Officer
Steve Hughes
Chief Medical Officer
Arthur A. Levin
Chief Scientific Officer
Teresa McCarthy
Chief Human Resources Officer
W. Michael Flanagan
Chief Scientific & Technical Officer
John W. Wallen III
General Counsel
Elizabeth J Ackermann PhD
Senior Vice President Clinical Development
Husam Younis
Senior Vice President
Joseph Johnston
SVP, Regulatory Affairs & Quality
Mike MacLean
Chief Financial Officer
Teresa Brandt, PhD
VP, Regulatory Affairs
Marc Morris, MD JD
VP, Drug Safety & Pharmacovigilance
Eric Mosbrooker
Chief Strategy Officer (cso)
Anneke Raney
Executive Director, Program And Alliance Management
Sarah Hudson, PhD, PMP®
Sr Director, Program And Alliance Management